Kidneys And Ureters Flashcards
CT protocol for renal masses
- Non contrast phase
- Corticomedullar phase (30 sec)
- Nephrogram phase (80-90 sec)
- Pyelogram phase (3-5 mins).
CT urogram protocol
- Non contrast phase
- Nephrogram phase (80 sec)
- Pyelogram phase (5-8 mins)
Horshoe kidney
congenital fusion of lower poles, 1/400 births, isthmus across the aorta below IMA, multiple abnormal renal arteries, urinary stasis, causes: stone formation, recurrent infection, x3-4 increased risk of TCC
Renal Masses important features
- Presence and type of calcifications
- Attenuation before and after contrast
- Margins with kidney and surrounding tissues,
- Prescence and thickness of wall septa and cystic masses.
Increase of attenuation of renal masses in UH in order to be significant
Beam hardening effect may increase attenuation of lesions by up to 10 UH
Therefore:
Enhancement: >20 UH
Equivocal enhancement: 10-20 UH
Non enhancement: <10 UH
Renal cell carcinoma types (6)
Clear cell, multilocular cystic RCC, papillary (Chomophil), chromophobe, hereditary cancer syndromes and others.
Clear cell RCC
70% RCC, heterogeneous (solid, cystic, foci of hemorrage and necrosis), hypervascularity (>84 UH, remains high), expansile growth, 5% bilateral
Multilocular cystic RCC
Variant of clear cell RCC, clusters of cysts, fibrous capsule and septa (20% calcified), slower growth and less metastases/recurrence
Papillary RCC (Chromophil)
10-15% RCC, from distal convoluted tubules, homogenous solid tumors (may be cystic), hypovascular. When large: hemorrage, necrosis and calcifications, 70% confined to the kidney, good prognosis with surgery
Chromophobe RCC
5% of RCC, from collecting duct cells, ultrasound: hyperechoic (similar to AML), Typically homogeneous enhacement, but may have: central scar, necrosis, calcifications, spoke-wheel pattern, good prognosis.
Hereditary cancer syndromes (renal)
5% of RCC
Early and bilateral development of RCC.
Von hippel lindau: Clear cell RCC
Birt hogg dube: Chromophobe RCC
Rare cell types of RCC
<1% of RCC
Renal medullary carcinoma: <40 years with sickle cell trait
Collecting duct RCC
Mucinous tubular and sprindle cell RCC
Traslocation (juvenile) RCC
Suspicion criteria for benign kidney solid masses
- Homogeneous lession <20 or >70 UH
- Size <3 cm (20% benign: oncocytoma, AML, papillary adenoma, metanephritic adenoma)
RCC signs of invasion
- Tumor growth into the main renal vein (20-35%) and IVC (4-10%)
- Filling defects in the collecting system
- Regional lymphnodes >2 cm is almost always a metastasic tumor
(1-2 cm are indeterminate) - Metastases: Lung, liver and bone
Recurrence of RCC
- Usually <6 years after surgery.
- Local recurrence in the renal fossa 5%.
- Lymphatic recurrence in nodes close to the renal vascular pedicle.
- Late metastases >10 years: Lung, pancreas, bone, skeletal muscle and bowel.
Renal Oncocytoma
Benign solid tumor, arises from proximal renal tubule, men 60s, 5% of renal neoplasms, no test can reliably differenciate from RCC, treatment is surgical
CT findings:
- Solitary, well-defined, arises from the cortex, Homogeneous attenuation after contrast
- Central, stellate, sharply marginated low attenuation central scar (33% of tumors)
- Inverted segmentary enhancement
- Can also be: heterogeneous attenuation, necrosis, hemorrage
Renal Angiomyolipoma Generalities
- Most common benign renal tumor.
- Angio: Might have aneurysms, high risk of hemorrage > 4 cm.
- Lipo: Pockets of fat <-10 UH is specific for AML (95%) (5% of AML are lipid-poor).
- CT findings: Cortical, well-marginated, solid and fat containing lesion.
Renal Angiomyolipoma common presentations (2)
- Sporadic and solitary (80-90%): Middle aged women
- Multifocal and bilateral (10-20%): Tuberous sclerosis
Lipid poor renal Angiomyolipoma vs RCC
- RCC often show other signs of malignancy.
- Intratumoral calcifications are never present in AML.
- AML has high attenuation on unhanced CT and show homogeneous increased attenuation on enhanced CT.
- Biopsy is usually required to differenciate them.
Renal Angiomyolipoma and tuberous sclerosis
- Multiple AML are found in both kidneys (80%).
- Multiple renal cysts (50%).
- AML are large and with high risk of hemorrage.
- 2-3% develop RCC at young age (average 28 years old).
Transitional cell carcinoma - Generalities
- 90% from the bladder, 10% from the upper tracts.
- Aditional TCC may be present synchronously.
- Most ureteral uroepithelial tumors (>70%) occur in the distal ureter.
- They appear as filling defect or circumferential thickening of the wall of the ureter.
- Calcifications might mimic lithiasis (5%).
- Advanced TCC might invade renal sinus fat, renal parenchyma, extrarenal extension, regional lymphnodes, metastases to lungs and bone.
- Rarely: invation of renal vein and IVC.
Transitional cell carcinoma - Upper tract Locations
- Filling defects in the renal pelvis (35%).
- Filling defects within dilated calyces (26%).
- Thickening of the wall of the renal pelvis (20%).
- Abscent or decreased contrast medium excretion (13%).
- Diffuse hydronephrosis with renal enlargement (6%).